CUA 2-Part Educational Session: Prostate Cancer & Renal Cell Carcinoma
DÉTAILS DE L’ACTIVITÉ
CRÉDITS
PART 1: Unraveling the Power of Precision Medicine with PARP Inhibitors
Speakers: Noel Clarke, Maria Jiang, Aly-Khan Lalani, Krista Noonan
Objectives:
- Discuss the importance of genetic testing for their patients with advanced prostate cancer
- Understand the efficacy and safety data from randomized control trials investigating PARPi in mCRPC
- Apply the practical knowledge gained from real world, case-based discussion surrounding PARPi use in patients with mCRPC
PART 2: Insights on Early Stage RCC Detection & Emerging Management Strategies
Speakers: Aly-Khan Lalani, Simon Tanguay
Objectives:
- Recognize early RCC disease stage symptoms and underlying risk factors associated with recurrence rates
- Assess emergent adjuvant RCC clinical trial data and their impact on current clinical practice
- Identify key patient factors important for the consideration of adjuvant therapy in early stage RCC